CTX vs. VIR, ZOM, IN, META, CWEB, LABS, DB, NRTH, MRV, and WLLW
Should you be buying Crescita Therapeutics stock or one of its competitors? The main competitors of Crescita Therapeutics include Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), InMed Pharmaceuticals (IN), Meta Growth (META), Charlotte's Web (CWEB), MediPharm Labs (LABS), Decibel Cannabis (DB), 48North Cannabis (NRTH), Nuvo Pharmaceuticals (MRV), and Willow Biosciences (WLLW). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Viridium Pacific Group (CVE:VIR) and Crescita Therapeutics (TSE:CTX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, community ranking, earnings, analyst recommendations and dividends.
Crescita Therapeutics received 20 more outperform votes than Viridium Pacific Group when rated by MarketBeat users. However, 83.33% of users gave Viridium Pacific Group an outperform vote while only 67.42% of users gave Crescita Therapeutics an outperform vote.
In the previous week, Viridium Pacific Group had 2 more articles in the media than Crescita Therapeutics. MarketBeat recorded 2 mentions for Viridium Pacific Group and 0 mentions for Crescita Therapeutics. Viridium Pacific Group's average media sentiment score of 0.34 beat Crescita Therapeutics' score of 0.00 indicating that Viridium Pacific Group is being referred to more favorably in the media.
Viridium Pacific Group has a net margin of 0.00% compared to Crescita Therapeutics' net margin of -17.72%. Viridium Pacific Group's return on equity of 0.00% beat Crescita Therapeutics' return on equity.
Crescita Therapeutics has higher revenue and earnings than Viridium Pacific Group. Crescita Therapeutics is trading at a lower price-to-earnings ratio than Viridium Pacific Group, indicating that it is currently the more affordable of the two stocks.
Summary
Viridium Pacific Group beats Crescita Therapeutics on 9 of the 12 factors compared between the two stocks.
Get Crescita Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CTX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Crescita Therapeutics Competitors List
Related Companies and Tools
